Showing 2,601 - 2,620 results of 2,691 for search 'Science Daily', query time: 0.07s Refine Results
  1. 2601
  2. 2602
  3. 2603
  4. 2604

    Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Ph... by Su H, Shang X, Liu H, Wang Y, Yu Y, Xu Y, Jiang K, Feng F

    Published 2025-02-01
    “…A total of 69 participants will receive low-dose lenvatinib (8 mg or 12 mg, daily, orally, based on patient’s body weight) and toripalimab (240 mg, every 21 days, intravenously). …”
    Get full text
    Article
  5. 2605
  6. 2606
  7. 2607
  8. 2608
  9. 2609
  10. 2610
  11. 2611
  12. 2612
  13. 2613
  14. 2614
  15. 2615
  16. 2616
  17. 2617
  18. 2618
  19. 2619
  20. 2620